EuroPCR 2023: Late-Breaking Science Video Collection
Published: 18 May 2023
-
Views:
2136
-
Likes:
7
-
Views:
2136
-
Likes:
7
-
5m 41sPart 1 | Session 1 EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions Sandeep Arunothayaraj
-
6m 12sPart 1 | Session 2 BASILICA Vs Chimney-Stenting for TAVR-Related Coronary Obstruction Antonio Mangieri
-
3m 15sPart 1 | Session 3 DRAGONFLY-DMR: Safety and Effectiveness of Dragonfly TMVR System for Mitral Regurgitation D Scott Lim
-
3m 30sPart 1 | Session 4 TRILUMINATE Pivotal: TEER for Tricuspid Regurgitation Paul Sorajja
-
6m 7sPart 1 | Session 5 EBC MAIN Three-Year Follow Up David Hildick-Smith
-
4m 59sPart 1 | Session 6 TVT Registry Analysis: TAVR in Patients with Cardiogenic Shock Abhijeet Dhoble
-
2m 35sPart 1 | Session 7 FAME III Three-Year Follow-Up Frederik Zimmermann
-
29m 21sPart 2 | Session 1 View from the Thoraxcenter: EuroPCR 23 Late-breaking Science Preview Joost Daemen, Nicolas M Van Mieghem
-
30m 41sPart 2 | Session 2 View from the Thoraxcenter: What's Hot at EuroPCR 23? Joost Daemen, Nicolas M Van Mieghem
-
4m 28sPart 3 3 Trials That Will Change Your Practice With Dr Mirvat Alasnag Mirvat Alasnag
-
1m 5sPart 4 | Session 1 Dr Lim: Patient Care and Finding Your Passion D Scott Lim
-
1m 51sPart 4 | Session 2 Dr Sandeep Arunothayaraj: Interventional Cardiology and His Advice To Young Investigators Sandeep Arunothayaraj
Overview
Our regular review series View From the Thoraxcenter, hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) dives deep into the late-breaking trials of EuroPCR 2023, spotlighting the impactful data.
For short, concise coverage of the key data revealed, our accessible Expert Interviews were conducted with select faculty, focussing on the results, applicability and impact on future research.
Hear commentary on the practice-changing trials of EuroPCR 2023 from selected faculty in our Highlights Reviews.
Watch our Behind the Heart Series to hear more from the personal perspectives of the investigators behind the top trials of EuroPCR 2023.
More from this programme
Part 1
Expert Interviews
Short, concise overviews of the key data revealed at EuroPCR 2023, focussing on the results and impact on future research.
Part 2
View from the Thoraxcenter
In these concise episodes of View from the Thoraxcenter, Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) offer their thoughts on the top late-breaking trials that will be presented at EuroPCR 2023.
Part 3
Highlights Reviews
Commentary on the top late-breaking trials of EuroPCR 2023, as chosen by selected faculty.
Part 4
Behind the Heart
Watch our Behind the Heart series to learn more the personal perspectives from the investigators behind top trials in cardiovascular science.
About the episode
In this short interview, Dr Paul Sorajja outlines his reasons for choosing to pursue cardiovascular medicine.
Faculty Biographies
Paul Sorajja
Director of the Center for Valve and Structural Heart Disease
Dr Paul Sorajja is an Interventional Cardiologist at the Minneapolis Heart Institute at Abbott Northwestern Hospital, where he is the Director of the Center for Valve and Structural Heart Disease.
Dr Sorajja's clinical practice specialises in interventional cardiology, with a focus on catheter-based therapy of valvular and structural heart disease. He was part of the team that performed the first transcatheter mitral valve replacement in the US for a patient with native mitral regurgitation in 2015, and has the highest worldwide experience with TMVR.
Dr Sorajja has published over 300 manuscripts and book chapters, with expertise in cardiac hemodynamics, clinical education, hypertrophic cardiomyopathy, and percutaneous therapy of structural heart disease.
Comments